-
1
-
-
84903584844
-
Endobiogeny: A global approach to systems biology (part 2 of 2)
-
J.C. Lapraz, K.M. Hedayat, and P. Pauly Endobiogeny: A global approach to systems biology (part 2 of 2) Glob Adv Health Med 2 2013 32 44
-
(2013)
Glob Adv Health Med
, vol.2
, pp. 32-44
-
-
Lapraz, J.C.1
Hedayat, K.M.2
Pauly, P.3
-
2
-
-
0038004636
-
Clinical biomarkers in drug discovery and development
-
R. Frank, and R. Hargreaves Clinical biomarkers in drug discovery and development Nat Rev Drug Discov 2 2003 566 580
-
(2003)
Nat Rev Drug Discov
, vol.2
, pp. 566-580
-
-
Frank, R.1
Hargreaves, R.2
-
5
-
-
84858433338
-
Biomarkers in diabetes: Hemoglobin A1c, vascular and tissue markers
-
T.J. Lyons, and A. Basu Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers Transl Res 159 2012 303 312
-
(2012)
Transl Res
, vol.159
, pp. 303-312
-
-
Lyons, T.J.1
Basu, A.2
-
6
-
-
70049113799
-
Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: Results from Sinikithemba Cohort, Durban, South Africa
-
Z. Brumme, B. Wang, K. Nair, C. Brumme, C. de Pierres, S. Reddy, and et al. Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa Clin Infect Dis 49 2009 956 964
-
(2009)
Clin Infect Dis
, vol.49
, pp. 956-964
-
-
Brumme, Z.1
Wang, B.2
Nair, K.3
Brumme, C.4
De Pierres, C.5
Reddy, S.6
-
7
-
-
33751515147
-
CD4+ count-guided interruption of antiretroviral treatment
-
Strategies for Management of Antiretroviral Therapy Study Group W.M. El-Sadr, J. Lundgren, J.D. Neaton, F. Gordin, D. Abrams, R.C. Arduino, and et al. CD4+ count-guided interruption of antiretroviral treatment N Engl J Med 355 2006 2283 2296
-
(2006)
N Engl J Med
, vol.355
, pp. 2283-2296
-
-
El-Sadr, W.M.1
Lundgren, J.2
Neaton, J.D.3
Gordin, F.4
Abrams, D.5
Arduino, R.C.6
-
8
-
-
76149146032
-
Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program
-
W.C. Moore, D.A. Meyers, S.E. Wenzel, W.G. Teague, H. Li, X. Li, and et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program Am J Respir Crit Care Med 181 2010 315 323
-
(2010)
Am J Respir Crit Care Med
, vol.181
, pp. 315-323
-
-
Moore, W.C.1
Meyers, D.A.2
Wenzel, S.E.3
Teague, W.G.4
Li, H.5
Li, X.6
-
9
-
-
84872604675
-
Personalised medicine and asthma diagnostics/management
-
S.J. Wadsworth, and A.J. Sandford Personalised medicine and asthma diagnostics/management Curr Allergy Asthma Rep 13 2013 118 129
-
(2013)
Curr Allergy Asthma Rep
, vol.13
, pp. 118-129
-
-
Wadsworth, S.J.1
Sandford, A.J.2
-
10
-
-
84882238835
-
Eosinophils in the spotlight: Eosinophilic airway inflammation in nonallergic asthma
-
G.G. Brusselle, T. Maes, and K.R. Bracke Eosinophils in the spotlight: eosinophilic airway inflammation in nonallergic asthma Nat Med 19 2013 977 979
-
(2013)
Nat Med
, vol.19
, pp. 977-979
-
-
Brusselle, G.G.1
Maes, T.2
Bracke, K.R.3
-
11
-
-
34249780819
-
Eosinophils: Singularly destructive effector cells or purveyors of immunoregulation?
-
E.A. Jacobsen, A.G. Taranova, N.A. Lee, and J.J. Lee Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? J Allergy Clin Immunol 119 2007 1313 1320
-
(2007)
J Allergy Clin Immunol
, vol.119
, pp. 1313-1320
-
-
Jacobsen, E.A.1
Taranova, A.G.2
Lee, N.A.3
Lee, J.J.4
-
13
-
-
0346041503
-
Distinguishing severe asthma phenotypes: Role of age at onset and eosinophilic inflammation
-
C. Miranda, A. Busacker, S. Balzar, J. Trudeau, and S.E. Wenzel Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation J Allergy Clin Immunol 113 2004 101 108
-
(2004)
J Allergy Clin Immunol
, vol.113
, pp. 101-108
-
-
Miranda, C.1
Busacker, A.2
Balzar, S.3
Trudeau, J.4
Wenzel, S.E.5
-
14
-
-
0026669245
-
Interleukin-5 modulates eosinophil accumulation in allergic Guinea pig lung
-
A.R. Gulbenkian, R.W. Egan, X. Fernandez, H. Jones, W. Kreutner, T. Kung, and et al. Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung Am Rev Respir Dis 146 1992 263 266
-
(1992)
Am Rev Respir Dis
, vol.146
, pp. 263-266
-
-
Gulbenkian, A.R.1
Egan, R.W.2
Fernandez, X.3
Jones, H.4
Kreutner, W.5
Kung, T.6
-
15
-
-
36749065556
-
A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma
-
P. Flood-Page, C. Swenson, I. Faiferman, J. Matthews, M. Williams, L. Brannick, and et al. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma Am J Respir Crit Care Med 176 2007 1062 1071
-
(2007)
Am J Respir Crit Care Med
, vol.176
, pp. 1062-1071
-
-
Flood-Page, P.1
Swenson, C.2
Faiferman, I.3
Matthews, J.4
Williams, M.5
Brannick, L.6
-
16
-
-
33344476409
-
Determining asthma treatment by monitoring sputum cell counts: Effect on exacerbations
-
L. Jayaram, M.M. Pizzichini, R.J. Cook, L.P. Boulet, C. Lemiere, E. Pizzichini, and et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations Eur Respir J 27 2006 483 494
-
(2006)
Eur Respir J
, vol.27
, pp. 483-494
-
-
Jayaram, L.1
Pizzichini, M.M.2
Cook, R.J.3
Boulet, L.P.4
Lemiere, C.5
Pizzichini, E.6
-
17
-
-
79959344460
-
Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma - Summary report 2007
-
National Asthma Education and Prevention Program Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma - summary report 2007 J Allergy Clin Immunol 120 suppl 2007 S94 S138
-
(2007)
J Allergy Clin Immunol
, vol.120
, pp. S94-S138
-
-
-
18
-
-
0037202790
-
Asthma exacerbations and sputum eosinophil counts: A randomised controlled trial
-
R.H. Green, C.E. Brightling, S. McKenna, B. Hargadon, D. Parker, P. Bradding, and et al. Asthma exacerbations and sputum eosinophil counts: A randomised controlled trial Lancet 360 2002 1715 1721
-
(2002)
Lancet
, vol.360
, pp. 1715-1721
-
-
Green, R.H.1
Brightling, C.E.2
McKenna, S.3
Hargadon, B.4
Parker, D.5
Bradding, P.6
-
19
-
-
0036795111
-
Analysis of induced sputum in adults with asthma: Identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids
-
R.H. Green, C.E. Brightling, G. Woltmann, D. Parker, A.J. Wardlaw, and I.D. Pavord Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids Thorax 57 2002 875 879
-
(2002)
Thorax
, vol.57
, pp. 875-879
-
-
Green, R.H.1
Brightling, C.E.2
Woltmann, G.3
Parker, D.4
Wardlaw, A.J.5
Pavord, I.D.6
-
20
-
-
61849086181
-
Mepolizumab and exacerbations of refractory eosinophilic asthma
-
P. Haldar, C.E. Brightling, B. Hargadon, S. Gupta, W. Monteiro, A. Sousa, and et al. Mepolizumab and exacerbations of refractory eosinophilic asthma N Engl J Med 360 2009 973 984
-
(2009)
N Engl J Med
, vol.360
, pp. 973-984
-
-
Haldar, P.1
Brightling, C.E.2
Hargadon, B.3
Gupta, S.4
Monteiro, W.5
Sousa, A.6
-
21
-
-
0030903524
-
Measuring airway inflammation in asthma: Eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood
-
E. Pizzichini, M.M. Pizzichini, A. Efthimiadis, J. Dolovich, and F.E. Hargreave Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood J Allergy Clin Immunol 99 1997 539 544
-
(1997)
J Allergy Clin Immunol
, vol.99
, pp. 539-544
-
-
Pizzichini, E.1
Pizzichini, M.M.2
Efthimiadis, A.3
Dolovich, J.4
Hargreave, F.E.5
-
22
-
-
84884908457
-
Exhaled nitric oxide and blood eosinophilia: Independent markers of preventable risk
-
I.D. Pavord, and M. Bafadhel Exhaled nitric oxide and blood eosinophilia: independent markers of preventable risk J Allergy Clin Immunol 132 2013 828 829
-
(2013)
J Allergy Clin Immunol
, vol.132
, pp. 828-829
-
-
Pavord, I.D.1
Bafadhel, M.2
-
23
-
-
84884905728
-
Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects
-
e1-5
-
A. Malinovschi, J.A. Fonseca, T. Jacinto, K. Alving, and C. Janson Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects J Allergy Clin Immunol 132 2013 821 827 e1-5
-
(2013)
J Allergy Clin Immunol
, vol.132
, pp. 821-827
-
-
Malinovschi, A.1
Fonseca, J.A.2
Jacinto, T.3
Alving, K.4
Janson, C.5
-
24
-
-
84865145614
-
Mepolizumab for severe eosinophilic asthma (DREAM): A multicentre, double-blind, placebo-controlled trial
-
I.D. Pavord, S. Korn, P. Howarth, E.R. Bleecker, R. Buhl, O.N. Keene, and et al. Mepolizumab for severe eosinophilic asthma (DREAM): A multicentre, double-blind, placebo-controlled trial Lancet 380 2012 651 659
-
(2012)
Lancet
, vol.380
, pp. 651-659
-
-
Pavord, I.D.1
Korn, S.2
Howarth, P.3
Bleecker, E.R.4
Buhl, R.5
Keene, O.N.6
-
25
-
-
84907423833
-
Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma
-
E.H. Bel, S.E. Wenzel, P.J. Thompson, C.M. Prazma, O.N. Keene, S.W. Yancey, and et al. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma N Engl J Med 371 2014 1189 1197
-
(2014)
N Engl J Med
, vol.371
, pp. 1189-1197
-
-
Bel, E.H.1
Wenzel, S.E.2
Thompson, P.J.3
Prazma, C.M.4
Keene, O.N.5
Yancey, S.W.6
-
26
-
-
84911874054
-
Cluster analysis and characterization of response to mepolizumab. A step closer to personalized medicine for patients with severe asthma
-
H. Ortega, H. Li, R. Suruki, F. Albers, D. Gordon, and S. Yancey Cluster analysis and characterization of response to mepolizumab. A step closer to personalized medicine for patients with severe asthma Ann Am Thorac Soc 11 2014 1011 1017
-
(2014)
Ann Am Thorac Soc
, vol.11
, pp. 1011-1017
-
-
Ortega, H.1
Li, H.2
Suruki, R.3
Albers, F.4
Gordon, D.5
Yancey, S.6
-
27
-
-
84887020563
-
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
-
M. Laviolette, D.L. Gossage, G. Gauvreau, R. Leigh, R. Olivenstein, R. Katial, and et al. Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia J Allergy Clin Immunol 132 2013 1086 1096.e5
-
(2013)
J Allergy Clin Immunol
, vol.132
, pp. 1086-1096e5
-
-
Laviolette, M.1
Gossage, D.L.2
Gauvreau, G.3
Leigh, R.4
Olivenstein, R.5
Katial, R.6
-
28
-
-
84876883293
-
Exploring the effects of omalizumab in allergic asthma: An analysis of biomarkers in the EXTRA study
-
N.A. Hanania, S. Wenzel, K. Rosen, H.J. Hsieh, S. Mosesova, D.F. Choy, and et al. Exploring the effects of omalizumab in allergic asthma: An analysis of biomarkers in the EXTRA study Am J Respir Crit Care Med 187 2013 804 811
-
(2013)
Am J Respir Crit Care Med
, vol.187
, pp. 804-811
-
-
Hanania, N.A.1
Wenzel, S.2
Rosen, K.3
Hsieh, H.J.4
Mosesova, S.5
Choy, D.F.6
-
29
-
-
84902244482
-
Current evidence and future research needs for FeNO measurement in respiratory diseases
-
L. Bjermer, K. Alving, Z. Diamant, H. Magnussen, I. Pavord, G. Piacentini, and et al. Current evidence and future research needs for FeNO measurement in respiratory diseases Respir Med 108 2014 830 841
-
(2014)
Respir Med
, vol.108
, pp. 830-841
-
-
Bjermer, L.1
Alving, K.2
Diamant, Z.3
Magnussen, H.4
Pavord, I.5
Piacentini, G.6
-
30
-
-
80052438246
-
An official ATS clinical practice guideline: Interpretation of exhaled nitric oxide levels (FENO) for clinical applications
-
R.A. Dweik, P.B. Boggs, S.C. Erzurum, C.G. Irvin, M.W. Leigh, J.O. Lundberg, and et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications Am J Respir Crit Care Med 184 2011 602 615
-
(2011)
Am J Respir Crit Care Med
, vol.184
, pp. 602-615
-
-
Dweik, R.A.1
Boggs, P.B.2
Erzurum, S.C.3
Irvin, C.G.4
Leigh, M.W.5
Lundberg, J.O.6
-
31
-
-
34250872265
-
Fraction of exhaled nitric oxide at 50 mL/s: Reference values for adult lifelong never-smokers
-
A.C. Olin, B. Bake, and K. Toren Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers Chest 131 2007 1852 1856
-
(2007)
Chest
, vol.131
, pp. 1852-1856
-
-
Olin, A.C.1
Bake, B.2
Toren, K.3
-
32
-
-
33745686504
-
Exhaled nitric oxide in healthy nonatopic school-age children: Determinants and height-adjusted reference values
-
L.P. Malmberg, T. Petays, T. Haahtela, T. Laatikainen, P. Jousilahti, E. Vartiainen, and et al. Exhaled nitric oxide in healthy nonatopic school-age children: determinants and height-adjusted reference values Pediatr Pulmonol 41 2006 635 642
-
(2006)
Pediatr Pulmonol
, vol.41
, pp. 635-642
-
-
Malmberg, L.P.1
Petays, T.2
Haahtela, T.3
Laatikainen, T.4
Jousilahti, P.5
Vartiainen, E.6
-
33
-
-
22744437851
-
High fractional concentration of nitric oxide in exhaled air despite steroid treatment in asthmatic children
-
M.W. Pijnenburg, E.M. Bakker, S. Lever, W.C. Hop, and J.C. De Jongste High fractional concentration of nitric oxide in exhaled air despite steroid treatment in asthmatic children Clin Exp Allergy 35 2005 920 925
-
(2005)
Clin Exp Allergy
, vol.35
, pp. 920-925
-
-
Pijnenburg, M.W.1
Bakker, E.M.2
Lever, S.3
Hop, W.C.4
De Jongste, J.C.5
-
34
-
-
0031675372
-
Exhaled nitric oxide and bronchial reactivity during and after inhaled beclomethasone in mild asthma
-
P.E. Silkoff, P.A. McClean, A.S. Slutsky, M. Caramori, K.R. Chapman, C. Gutierrez, and et al. Exhaled nitric oxide and bronchial reactivity during and after inhaled beclomethasone in mild asthma J Asthma 35 1998 473 479
-
(1998)
J Asthma
, vol.35
, pp. 473-479
-
-
Silkoff, P.E.1
McClean, P.A.2
Slutsky, A.S.3
Caramori, M.4
Chapman, K.R.5
Gutierrez, C.6
-
35
-
-
79955022468
-
Exhaled nitric oxide in asthma in adults: The end is the beginning?
-
K. Kostikas, M. Minas, A.I. Papaioannou, S. Papiris, and R.A. Dweik Exhaled nitric oxide in asthma in adults: the end is the beginning? Curr Med Chem 18 2011 1423 1431
-
(2011)
Curr Med Chem
, vol.18
, pp. 1423-1431
-
-
Kostikas, K.1
Minas, M.2
Papaioannou, A.I.3
Papiris, S.4
Dweik, R.A.5
-
36
-
-
74549216073
-
Utility of exhaled nitric oxide in the diagnosis and management of asthma
-
H. Majid, and C. Kao Utility of exhaled nitric oxide in the diagnosis and management of asthma Curr Opin Pulm Med 16 2010 42 47
-
(2010)
Curr Opin Pulm Med
, vol.16
, pp. 42-47
-
-
Majid, H.1
Kao, C.2
-
37
-
-
43649089543
-
The use of fraction of exhaled nitric oxide in pulmonary practice
-
K.G. Lim, and C. Mottram The use of fraction of exhaled nitric oxide in pulmonary practice Chest 133 2008 1232 1242
-
(2008)
Chest
, vol.133
, pp. 1232-1242
-
-
Lim, K.G.1
Mottram, C.2
-
38
-
-
0035448093
-
The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control
-
S.L. Jones, J. Kittelson, J.O. Cowan, E.M. Flannery, R.J. Hancox, C.R. McLachlan, and et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control Am J Respir Crit Care Med 164 2001 738 743
-
(2001)
Am J Respir Crit Care Med
, vol.164
, pp. 738-743
-
-
Jones, S.L.1
Kittelson, J.2
Cowan, J.O.3
Flannery, E.M.4
Hancox, R.J.5
McLachlan, C.R.6
-
39
-
-
14944353086
-
Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission
-
M.W. Pijnenburg, W. Hofhuis, W.C. Hop, and J.C. De Jongste Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission Thorax 60 2005 215 218
-
(2005)
Thorax
, vol.60
, pp. 215-218
-
-
Pijnenburg, M.W.1
Hofhuis, W.2
Hop, W.C.3
De Jongste, J.C.4
-
40
-
-
0037794333
-
Comparison of airway immunopathology of eosinophilic bronchitis and asthma
-
C.E. Brightling, F.A. Symon, S.S. Birring, P. Bradding, A.J. Wardlaw, and I.D. Pavord Comparison of airway immunopathology of eosinophilic bronchitis and asthma Thorax 58 2003 528 532
-
(2003)
Thorax
, vol.58
, pp. 528-532
-
-
Brightling, C.E.1
Symon, F.A.2
Birring, S.S.3
Bradding, P.4
Wardlaw, A.J.5
Pavord, I.D.6
-
41
-
-
4444232912
-
Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma
-
R. Djukanovic, S.J. Wilson, M. Kraft, N.N. Jarjour, M. Steel, K.F. Chung, and et al. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma Am J Respir Crit Care Med 170 2004 583 593
-
(2004)
Am J Respir Crit Care Med
, vol.170
, pp. 583-593
-
-
Djukanovic, R.1
Wilson, S.J.2
Kraft, M.3
Jarjour, N.N.4
Steel, M.5
Chung, K.F.6
-
42
-
-
44749088421
-
Exhaled nitric oxide: Independent effects of atopy, smoking, respiratory tract infection, gender and height
-
H. Dressel, D. de la Motte, J. Reichert, U. Ochmann, R. Petru, P. Angerer, and et al. Exhaled nitric oxide: independent effects of atopy, smoking, respiratory tract infection, gender and height Respir Med 102 2008 962 969
-
(2008)
Respir Med
, vol.102
, pp. 962-969
-
-
Dressel, H.1
De La Motte, D.2
Reichert, J.3
Ochmann, U.4
Petru, R.5
Angerer, P.6
-
43
-
-
0032707922
-
Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis
-
C. Gratziou, M. Lignos, M. Dassiou, and C. Roussos Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis Eur Respir J 14 1999 897 901
-
(1999)
Eur Respir J
, vol.14
, pp. 897-901
-
-
Gratziou, C.1
Lignos, M.2
Dassiou, M.3
Roussos, C.4
-
44
-
-
0035662429
-
Airway inflammation is present during clinical remission of atopic asthma
-
L.M. van den Toorn, S.E. Overbeek, J.C. de Jongste, K. Leman, H.C. Hoogsteden, and J.B. Prins Airway inflammation is present during clinical remission of atopic asthma Am J Respir Crit Care Med 164 2001 2107 2113
-
(2001)
Am J Respir Crit Care Med
, vol.164
, pp. 2107-2113
-
-
Van Den Toorn, L.M.1
Overbeek, S.E.2
De Jongste, J.C.3
Leman, K.4
Hoogsteden, H.C.5
Prins, J.B.6
-
45
-
-
34249669242
-
Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics
-
S. Komakula, S. Khatri, J. Mermis, S. Savill, S. Haque, M. Rojas, and et al. Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics Respir Res 8 2007 32
-
(2007)
Respir Res
, vol.8
, pp. 32
-
-
Komakula, S.1
Khatri, S.2
Mermis, J.3
Savill, S.4
Haque, S.5
Rojas, M.6
-
46
-
-
20444502093
-
Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years
-
F. Buchvald, E. Baraldi, S. Carraro, B. Gaston, J. De Jongste, M.W. Pijnenburg, and et al. Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years J Allergy Clin Immunol 115 2005 1130 1136
-
(2005)
J Allergy Clin Immunol
, vol.115
, pp. 1130-1136
-
-
Buchvald, F.1
Baraldi, E.2
Carraro, S.3
Gaston, B.4
De Jongste, J.5
Pijnenburg, M.W.6
-
47
-
-
41649098873
-
Factors affecting exhaled nitric oxide measurements: The effect of sex
-
D.R. Taylor, P. Mandhane, J.M. Greene, R.J. Hancox, S. Filsell, C.R. McLachlan, and et al. Factors affecting exhaled nitric oxide measurements: the effect of sex Respir Res 8 2007 82
-
(2007)
Respir Res
, vol.8
, pp. 82
-
-
Taylor, D.R.1
Mandhane, P.2
Greene, J.M.3
Hancox, R.J.4
Filsell, S.5
McLachlan, C.R.6
-
48
-
-
35649028488
-
Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids
-
P.G. Woodruff, H.A. Boushey, G.M. Dolganov, C.S. Barker, Y.H. Yang, S. Donnelly, and et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids Proc Natl Acad Sci U S A 104 2007 15858 15863
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 15858-15863
-
-
Woodruff, P.G.1
Boushey, H.A.2
Dolganov, G.M.3
Barker, C.S.4
Yang, Y.H.5
Donnelly, S.6
-
49
-
-
69249150516
-
T-helper type 2-driven inflammation defines major subphenotypes of asthma
-
P.G. Woodruff, B. Modrek, D.F. Choy, G. Jia, A.R. Abbas, A. Ellwanger, and et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma Am J Respir Crit Care Med 180 2009 388 395
-
(2009)
Am J Respir Crit Care Med
, vol.180
, pp. 388-395
-
-
Woodruff, P.G.1
Modrek, B.2
Choy, D.F.3
Jia, G.4
Abbas, A.R.5
Ellwanger, A.6
-
50
-
-
0037393323
-
IL-13 receptors and signaling pathways: An evolving web
-
G.K. Hershey IL-13 receptors and signaling pathways: An evolving web J Allergy Clin Immunol 111 2003 677 691
-
(2003)
J Allergy Clin Immunol
, vol.111
, pp. 677-691
-
-
Hershey, G.K.1
-
51
-
-
84455188941
-
Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma
-
e1-9
-
A. Shikotra, D.F. Choy, C.M. Ohri, E. Doran, C. Butler, B. Hargadon, and et al. Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma J Allergy Clin Immunol 129 2012 104 111 e1-9
-
(2012)
J Allergy Clin Immunol
, vol.129
, pp. 104-111
-
-
Shikotra, A.1
Choy, D.F.2
Ohri, C.M.3
Doran, E.4
Butler, C.5
Hargadon, B.6
-
52
-
-
80053084755
-
Lebrikizumab treatment in adults with asthma
-
J. Corren, R.F. Lemanske, N.A. Hanania, P.E. Korenblat, M.V. Parsey, J.R. Arron, and et al. Lebrikizumab treatment in adults with asthma N Engl J Med 365 2011 1088 1098
-
(2011)
N Engl J Med
, vol.365
, pp. 1088-1098
-
-
Corren, J.1
Lemanske, R.F.2
Hanania, N.A.3
Korenblat, P.E.4
Parsey, M.V.5
Arron, J.R.6
-
53
-
-
84891947803
-
Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma
-
S. Agrawal, and R.G. Townley Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma Expert Opin Biol Ther 14 2014 165 181
-
(2014)
Expert Opin Biol Ther
, vol.14
, pp. 165-181
-
-
Agrawal, S.1
Townley, R.G.2
-
54
-
-
84865696394
-
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
-
G. Jia, R.W. Erickson, D.F. Choy, S. Mosesova, L.C. Wu, O.D. Solberg, and et al. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients J Allergy Clin Immunol 130 2012 647 654.e10
-
(2012)
J Allergy Clin Immunol
, vol.130
, pp. 647-654e10
-
-
Jia, G.1
Erickson, R.W.2
Choy, D.F.3
Mosesova, S.4
Wu, L.C.5
Solberg, O.D.6
-
55
-
-
84901983441
-
The role of periostin in tissue remodeling across health and disease
-
S.J. Conway, K. Izuhara, Y. Kudo, J. Litvin, R. Markwald, G. Ouyang, and et al. The role of periostin in tissue remodeling across health and disease Cell Mol Life Sci 71 2014 1279 1288
-
(2014)
Cell Mol Life Sci
, vol.71
, pp. 1279-1288
-
-
Conway, S.J.1
Izuhara, K.2
Kudo, Y.3
Litvin, J.4
Markwald, R.5
Ouyang, G.6
-
56
-
-
78649593533
-
Increased expression and serum levels of the stromal cell-secreted protein periostin in breast cancer bone metastases
-
S. Contie, N. Voorzanger-Rousselot, J. Litvin, P. Clezardin, and P. Garnero Increased expression and serum levels of the stromal cell-secreted protein periostin in breast cancer bone metastases Int J Cancer 128 2011 352 360
-
(2011)
Int J Cancer
, vol.128
, pp. 352-360
-
-
Contie, S.1
Voorzanger-Rousselot, N.2
Litvin, J.3
Clezardin, P.4
Garnero, P.5
-
57
-
-
84987596902
-
Periostin is a novel therapeutic target that predicts and regulates glioma malignancy
-
A.M. Mikheev, S.A. Mikheeva, A.D. Trister, M.J. Tokita, S.N. Emerson, C.A. Parada, and et al. Periostin is a novel therapeutic target that predicts and regulates glioma malignancy Neuro Oncol 17 2015 372 382
-
(2015)
Neuro Oncol
, vol.17
, pp. 372-382
-
-
Mikheev, A.M.1
Mikheeva, S.A.2
Trister, A.D.3
Tokita, M.J.4
Emerson, S.N.5
Parada, C.A.6
-
58
-
-
33344467233
-
Incorporating anti-IgE (omalizumab) therapy into pulmonary medicine practice: Practice management implications
-
P. Marcus Practice Management Committee, American College of Chest Physicians Incorporating anti-IgE (omalizumab) therapy into pulmonary medicine practice: practice management implications Chest 129 2006 466 474
-
(2006)
Chest
, vol.129
, pp. 466-474
-
-
Marcus, P.1
-
59
-
-
84863229915
-
Asthma outcomes: Biomarkers
-
S.J. Szefler, S. Wenzel, R. Brown, S.C. Erzurum, J.V. Fahy, R.G. Hamilton, and et al. Asthma outcomes: biomarkers J Allergy Clin Immunol 129 suppl 2012 S9 S23
-
(2012)
J Allergy Clin Immunol
, vol.129
, pp. S9-S23
-
-
Szefler, S.J.1
Wenzel, S.2
Brown, R.3
Erzurum, S.C.4
Fahy, J.V.5
Hamilton, R.G.6
-
60
-
-
0035114065
-
Efficacy of a single diagnostic test for sensitization to common inhalant allergens
-
P.B. Williams, C. Siegel, and J. Portnoy Efficacy of a single diagnostic test for sensitization to common inhalant allergens Ann Allergy Asthma Immunol 86 2001 196 202
-
(2001)
Ann Allergy Asthma Immunol
, vol.86
, pp. 196-202
-
-
Williams, P.B.1
Siegel, C.2
Portnoy, J.3
-
62
-
-
84943351933
-
Markers of differential response to inhaled corticosteroid treatment among children with mild persistent asthma
-
J.K. Gerald, L.B. Gerald, M.M. Vasquez, W.J. Morgan, S.J. Boehmer, R.F. Lemanske Jr., and et al. Markers of differential response to inhaled corticosteroid treatment among children with mild persistent asthma J Allergy Clin Immunol Pract 3 2015 540 546.e3
-
(2015)
J Allergy Clin Immunol Pract
, vol.3
, pp. 540-546e3
-
-
Gerald, J.K.1
Gerald, L.B.2
Vasquez, M.M.3
Morgan, W.J.4
Boehmer, S.J.5
Lemanske, R.F.6
-
63
-
-
25844488069
-
IgE antibody quantification and the probability of wheeze in preschool children
-
A. Simpson, L. Soderstrom, S. Ahlstedt, C.S. Murray, A. Woodcock, and A. Custovic IgE antibody quantification and the probability of wheeze in preschool children J Allergy Clin Immunol 116 2005 744 749
-
(2005)
J Allergy Clin Immunol
, vol.116
, pp. 744-749
-
-
Simpson, A.1
Soderstrom, L.2
Ahlstedt, S.3
Murray, C.S.4
Woodcock, A.5
Custovic, A.6
-
64
-
-
0347994989
-
Quantification of IgE antibodies simplifies the classification of allergic diseases in 4-year-old children. A report from the prospective birth cohort study - BAMSE
-
M. Wickman, S. Ahlstedt, G. Lilja, and M. van Hage Hamsten Quantification of IgE antibodies simplifies the classification of allergic diseases in 4-year-old children. A report from the prospective birth cohort study - BAMSE Pediatr Allergy Immunol 14 2003 441 447
-
(2003)
Pediatr Allergy Immunol
, vol.14
, pp. 441-447
-
-
Wickman, M.1
Ahlstedt, S.2
Lilja, G.3
Van Hage Hamsten, M.4
-
65
-
-
84895058912
-
Childhood asthma clusters and response to therapy in clinical trials
-
T.S. Chang, R.F. Lemanske Jr., D.T. Mauger, A.M. Fitzpatrick, C.A. Sorkness, S.J. Szefler, and et al. Childhood asthma clusters and response to therapy in clinical trials J Allergy Clin Immunol 133 2014 363 369
-
(2014)
J Allergy Clin Immunol
, vol.133
, pp. 363-369
-
-
Chang, T.S.1
Lemanske, R.F.2
Mauger, D.T.3
Fitzpatrick, A.M.4
Sorkness, C.A.5
Szefler, S.J.6
-
66
-
-
0035888750
-
Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders
-
E.S. Schulman Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders Am J Respir Crit Care Med 164 suppl 2001 S6 S11
-
(2001)
Am J Respir Crit Care Med
, vol.164
, pp. S6-S11
-
-
Schulman, E.S.1
-
67
-
-
84924113230
-
Biologics in asthma - The next step toward personalized treatment
-
J. Darveaux, and W.W. Busse Biologics in asthma - the next step toward personalized treatment J Allergy Clin Immunol Pract 3 2015 152 161
-
(2015)
J Allergy Clin Immunol Pract
, vol.3
, pp. 152-161
-
-
Darveaux, J.1
Busse, W.W.2
-
68
-
-
3442891695
-
Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma
-
J. Bousquet, S. Wenzel, S. Holgate, W. Lumry, P. Freeman, and H. Fox Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma Chest 125 2004 1378 1386
-
(2004)
Chest
, vol.125
, pp. 1378-1386
-
-
Bousquet, J.1
Wenzel, S.2
Holgate, S.3
Lumry, W.4
Freeman, P.5
Fox, H.6
-
69
-
-
79952795093
-
Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children
-
W.W. Busse, W.J. Morgan, P.J. Gergen, H.E. Mitchell, J.E. Gern, A.H. Liu, and et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children N Engl J Med 364 2011 1005 1015
-
(2011)
N Engl J Med
, vol.364
, pp. 1005-1015
-
-
Busse, W.W.1
Morgan, W.J.2
Gergen, P.J.3
Mitchell, H.E.4
Gern, J.E.5
Liu, A.H.6
-
70
-
-
84922561723
-
Omalizumab in asthma: An update on recent developments
-
M. Humbert, W. Busse, N.A. Hanania, P.J. Lowe, J. Canvin, V.J. Erpenbeck, and et al. Omalizumab in asthma: An update on recent developments J Allergy Clin Immunol Pract 2 2014 525 536.e1
-
(2014)
J Allergy Clin Immunol Pract
, vol.2
, pp. 525-536e1
-
-
Humbert, M.1
Busse, W.2
Hanania, N.A.3
Lowe, P.J.4
Canvin, J.5
Erpenbeck, V.J.6
-
72
-
-
84890026323
-
Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma
-
W.W. Busse, S. Holgate, E. Kerwin, Y. Chon, J. Feng, J. Lin, and et al. Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma Am J Respir Crit Care Med 188 2013 1294 1302
-
(2013)
Am J Respir Crit Care Med
, vol.188
, pp. 1294-1302
-
-
Busse, W.W.1
Holgate, S.2
Kerwin, E.3
Chon, Y.4
Feng, J.5
Lin, J.6
|